Lincoln Capital Corp increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 0.8% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,463 shares of the healthcare conglomerate’s stock after purchasing an additional 103 shares during the quarter. UnitedHealth Group accounts for approximately 3.0% of Lincoln Capital Corp’s investment portfolio, making the stock its 10th largest holding. Lincoln Capital Corp’s holdings in UnitedHealth Group were worth $7,287,000 at the end of the most recent quarter.
Other large investors have also made changes to their positions in the company. Tealwood Asset Management Inc. acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $2,905,000. Vantage Investment Partners LLC grew its stake in UnitedHealth Group by 42.2% during the 1st quarter. Vantage Investment Partners LLC now owns 152,107 shares of the healthcare conglomerate’s stock valued at $75,247,000 after acquiring an additional 45,173 shares in the last quarter. Asset Planning Services Inc. LA ADV increased its holdings in shares of UnitedHealth Group by 1.2% during the 3rd quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock worth $7,288,000 after buying an additional 150 shares during the last quarter. Sequoia Financial Advisors LLC grew its position in UnitedHealth Group by 13.7% in the third quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock worth $14,603,000 after acquiring an additional 3,006 shares during the period. Finally, Maryland State Retirement & Pension System raised its position in UnitedHealth Group by 0.6% in the first quarter. Maryland State Retirement & Pension System now owns 72,689 shares of the healthcare conglomerate’s stock valued at $35,126,000 after purchasing an additional 469 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group Trading Up 0.7 %
NYSE UNH opened at $564.56 on Friday. The firm has a market cap of $521.33 billion, a PE ratio of 36.78, a P/E/G ratio of 1.67 and a beta of 0.58. The firm’s fifty day moving average is $583.52 and its two-hundred day moving average is $537.42. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $608.63.
UnitedHealth Group Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.49%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on UNH shares. Robert W. Baird lifted their price target on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. HSBC downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Stephens dropped their price objective on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and raised their price target for the company from $481.00 to $647.00 in a research report on Wednesday, July 17th. Finally, KeyCorp started coverage on UnitedHealth Group in a report on Friday, October 11th. They set an “overweight” rating and a $675.00 price target on the stock. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $615.53.
Get Our Latest Stock Report on UnitedHealth Group
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- Stock Average Calculator
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- Stock Sentiment Analysis: How it Works
- MarketBeat Week in Review – 10/21- 10/25
- What is the S&P 500 and How It is Distinct from Other Indexes
- Texas Roadhouse Stock Steering for New Highs This Year
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.